|
1
|
Kandukuri SR and Rao J: FIGO 2013 staging
system for ovarian cancer: What is new in comparison to the 1988
staging system? Curr Opin Obstet Gynecol. 27:48–52. 2015.
View Article : Google Scholar
|
|
2
|
Tew WP and Fleming GF: Treatment of
ovarian cancer in the older woman. Gynecol Oncol. 136:136–142.
2015. View Article : Google Scholar
|
|
3
|
Musto A, Grassetto G, Marzola MC, Rampin
L, Chondrogiannis S, Maffione AM, Colletti PM, Perkins AC, Fagioli
G and Rubello D: Management of epithelial ovarian cancer from
diagnosis to restaging: An overview of the role of imaging
techniques with particular regard to the contribution of 18F-FDG
PET/CT. Nucl Med Commun. 35:588–597. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Nathan JA and Lehner PJ: The trafficking
and regulation of membrane receptors by the RING-CH ubiquitin E3
ligases. Exp Cell Res. 315:1593–1600. 2009. View Article : Google Scholar
|
|
5
|
Ohmura-Hoshino M, Goto E, Matsuki Y, Aoki
M, Mito M, Uematsu M, Hotta H and Ishido S: A novel family of
membrane-bound E3 ubiquitin ligases. J Biochem. 140:147–154. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jabbour M, Campbell EM, Fares H and
Lybarger L: Discrete domains of MARCH1 mediate its localization,
functional interactions, and posttranscriptional control of
expression. J Immunol. 183:6500–6512. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bourgeois-Daigneault MC and Thibodeau J:
Identification of a novel motif that affects the conformation and
activity of the MARCH1 E3 ubiquitin ligase. J Cell Sci.
126:989–998. 2013. View Article : Google Scholar
|
|
8
|
Corcoran K, Jabbour M, Bhagwandin C,
Deymier MJ, Theisen DL and Lybarger L: Ubiquitin-mediated
regulation of CD86 protein expression by the ubiquitin ligase
membrane-associated RING-CH-1 (MARCH1). J Biol Chem.
286:37168–37180. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tze LE, Horikawa K, Domaschenz H, Howard
DR, Roots CM, Rigby RJ, Way DA, Ohmura-Hoshino M, Ishido S,
Andoniou CE, et al: CD83 increases MHC II and CD86 on dendritic
cells by opposing IL-10-driven MARCH1-mediated ubiquitination and
degradation. J Exp Med. 208:149–165. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chattopadhyay G and Shevach EM:
Antigen-specific induced T regulatory cells impair dendritic cell
function via an IL-10/MARCH1-dependent mechanism. J Immunol.
191:5875–5884. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bourgeois-Daigneault MC and Thibodeau J:
Autoregulation of MARCH1 expression by dimerization and
autoubiquitination. J Immunol. 188:4959–4970. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Matsuki Y, Ohmura-Hoshino M, Goto E, Aoki
M, Mito-Yoshida M, Uematsu M, Hasegawa T, Koseki H, Ohara O,
Nakayama M, et al: Novel regulation of MHC class II function in B
cells. EMBO J. 26:846–854. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Chen R, Li M, Zhang Y, Zhou Q and Shu HB:
The E3 ubiquitin ligase MARCH8 negatively regulates IL-1β-induced
NF-κB activation by targeting the IL1RAP coreceptor for
ubiquitination and degradation. Proc Natl Acad Sci USA.
109:14128–14133. 2012. View Article : Google Scholar
|
|
14
|
van de Kooij B, Verbrugge I, de Vries E,
Gijsen M, Montserrat V, Maas C, Neefjes J and Borst J:
Ubiquitination by the membrane-associated RING-CH-8 (MARCH-8)
ligase controls steady-state cell surface expression of tumor
necrosis factor-related apoptosis inducing ligand (TRAIL) receptor
1. J Biol Chem. 288:6617–6628. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hayden MS and Ghosh S: Signaling to
NF-kappaB. Genes Dev. 18:2195–2224. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Fujita T, Nolan GP, Ghosh S and Baltimore
D: Independent modes of transcriptional activation by the p50 and
p65 subunits of NF-kappa B. Genes Dev. 6:775–787. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Woronicz JD, Gao X, Cao Z, Rothe M and
Goeddel DV: IkappaB kinase-beta: NF-kappaB activation and complex
formation with IkappaB kinase-alpha and NIK. Science. 278:866–869.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schreck R, Albermann K and Baeuerle PA:
Nuclear factor kappa B: An oxidative stress-responsive
transcription factor of eukaryotic cells (a review). Free Radic Res
Commun. 17:221–237. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Logan CY and Nusse R: The Wnt signaling
pathway in development and disease. Annu Rev Cell Dev Biol.
20:781–810. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Neth P, Ries C, Karow M, Egea V, Ilmer M
and Jochum M: The Wnt signal transduction pathway in stem cells and
cancer cells: Influence on cellular invasion. Stem Cell Rev.
3:18–29. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Katoh M and Katoh M: WNT signaling pathway
and stem cell signaling network. Clin Cancer Res. 13:4042–4045.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheng CW, Wu PE, Yu JC, Huang CS, Yue CT,
Wu CW and Shen CY: Mechanisms of inactivation of E-cadherin in
breast carcinoma: Modification of the two-hit hypothesis of tumor
suppressor gene. Oncogene. 20:3814–3823. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Berx G, Cleton-Jansen AM, Nollet F, de
Leeuw WJ, van de Vijver M, Cornelisse C and van Roy F: E-cadherin
is a tumour/invasion suppressor gene mutated in human lobular
breast cancers. EMBO J. 14:6107–6115. 1995.PubMed/NCBI
|
|
24
|
Gottardi CJ, Wong E and Gumbiner BM:
E-cadherin suppresses cellular transformation by inhibiting
beta-catenin signaling in an adhesion-independent manner. J Cell
Biol. 153:1049–1060. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nelson WJ and Nusse R: Convergence of Wnt,
beta-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mantovani A, Allavena P, Sica A and
Balkwill F: Cancer-related inflammation. Nature. 454:436–444. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Liotta LA and Kohn EC: The
microenvironment of the tumour-host interface. Nature. 411:375–379.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
29
|
Tak PP and Firestein GS: NF-kappaB: A key
role in inflammatory diseases. J Clin Invest. 107:7–11. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ghosh S, May MJ and Kopp EB: NF-kappa B
and Rel proteins: Evolutionarily conserved mediators of immune
responses. Annu Rev Immunol. 16:225–260. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Van Antwerp DJ, Martin SJ, Kafri T, Green
DR and Verma IM: Suppression of TNF-alpha-induced apoptosis by
NF-kappaB. Science. 274:787–789. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Micheau O, Lens S, Gaide O, Alevizopoulos
K and Tschopp J: NF-kappaB signals induce the expression of c-FLIP.
Mol Cell Biol. 21:5299–5305. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Thomas RP, Farrow BJ, Kim S, May MJ,
Hellmich MR and Evers BM: Selective targeting of the nuclear
factor-kappaB pathway enhances tumor necrosis factor-related
apoptosis-inducing ligand-mediated pancreatic cancer cell death.
Surgery. 132:127–134. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Guttridge DC, Albanese C, Reuther JY,
Pestell RG and Baldwin AS Jr: NF-kappaB controls cell growth and
differentiation through transcriptional regulation of cyclin D1.
Mol Cell Biol. 19:5785–5799. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Chen F, Castranova V and Shi X: New
insights into the role of nuclear factor-kappaB in cell growth
regulation. Am J Pathol. 159:387–397. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Dolcet X, Llobet D, Pallares J and
Matias-Guiu X: NF-kB in development and progression of human
cancer. Virchows Arch. 446:475–482. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Sirotkin AV, Alexa R, Kišová G, Harrath
AH, Alwasel S, Ovcharenko D and Mlynček M: MicroRNAs control
transcription factor NF-kB (p65) expression in human ovarian cells.
Funct Integr Genomics. 15:271–275. 2015. View Article : Google Scholar
|
|
38
|
Cafferata EG, Guerrico AM, Pivetta OH and
Santa-Coloma TA: NF-kappaB activation is involved in regulation of
cystic fibrosis transmembrane conductance regulator (CFTR) by
interleukin-1beta. J Biol Chem. 276:15441–15444. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lu Z, Ghosh S, Wang Z and Hunter T:
Downregulation of caveolin-1 function by EGF leads to the loss of
E-cadherin, increased transcriptional activity of beta-catenin, and
enhanced tumor cell invasion. Cancer Cell. 4:499–515. 2003.
View Article : Google Scholar
|
